SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Speculating in Takeover Targets
ULBI 6.930+0.7%12:02 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Grantcw who wrote (2758)3/24/2011 1:53:21 PM
From: richardred  Read Replies (3) of 7242
 
>I'm not looking for the world from SVNT, but I do think that its current valuation is low given its prospects, buyout or not.

Grant I have to agree with you.
The stock price seems to have stabilized now. I can only guess that most of the downside news is built into the stock price. It would seem to me a potential buyer would eventually seek a first line indication for their drug. SVNT doesn't have the money for that on its own. Having a experienced CEO helps build potential value. I'm done adding. I've acquired a cost averaging stake. I'm willing to wait just like some of the more recent funds that have bought in after the debacle. Maybe within a year or two? IMO prospects will be more defined after a year.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext